Chloroquine and the fungal phagosome (Q34022942)

30 July 2017

1 reference

title

Chloroquine and the fungal phagosome (English)

1 reference

30 July 2017

0 references

Weber SM

1

1 reference

30 July 2017

Levitz SM

series ordinal

2

1 reference

30 July 2017

Harrison TS

series ordinal

3

1 reference

30 July 2017

language of work or name

1 reference

1 August 2000

1 reference

Current Opinion in Microbiology

30 July 2017

1 reference

30 July 2017

3

1 reference

30 July 2017

4

1 reference

30 July 2017

349-353

1 reference

4-Aminoquinolines--past, present, and future: a chemical perspective

30 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1369-5274%2800%2900102-8

7 January 2021

Chloroquine inhibits the intracellular multiplication of Legionella pneumophila by limiting the availability of iron. A potential new mechanism for the therapeutic effect of chloroquine against intracellular pathogens

1 reference

https://api.crossref.org/works/10.1016%2FS1369-5274%2800%2900102-8

7 January 2021

Chloroquine induces human macrophage killing of Histoplasma capsulatum by limiting the availability of intracellular iron and is therapeutic in a murine model of histoplasmosis

1 reference

https://api.crossref.org/works/10.1016%2FS1369-5274%2800%2900102-8

7 January 2021

Histoplasma capsulatum modulates the acidification of phagolysosomes

1 reference

https://api.crossref.org/works/10.1016%2FS1369-5274%2800%2900102-8

7 January 2021

Cloning and sequence analysis of an H(+)-ATPase-encoding gene from the human dimorphic pathogen Histoplasma capsulatum.

1 reference

https://api.crossref.org/works/10.1016%2FS1369-5274%2800%2900102-8

7 January 2021

Inhibition of growth of Histoplasma capsulatum yeast cells in human macrophages by the iron chelator VUF 8514 and comparison of VUF 8514 with deferoxamine

1 reference

https://api.crossref.org/works/10.1016%2FS1369-5274%2800%2900102-8

7 January 2021

Iron limitation and the gamma interferon-mediated antihistoplasma state of murine macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS1369-5274%2800%2900102-8

7 January 2021

Chloroquine induces human mononuclear phagocytes to inhibit and kill Cryptococcus neoformans by a mechanism independent of iron deprivation

1 reference

https://api.crossref.org/works/10.1016%2FS1369-5274%2800%2900102-8

7 January 2021

Cryptococcus neoformans resides in an acidic phagolysosome of human macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS1369-5274%2800%2900102-8

7 January 2021

Susceptibility of melanized and nonmelanized Cryptococcus neoformans to the melanin-binding compounds trifluoperazine and chloroquine.

1 reference

https://api.crossref.org/works/10.1016%2FS1369-5274%2800%2900102-8

7 January 2021

Acidification of the lysosome-like vacuole and the vacuolar H+-ATPase are deficient in two yeast mutants that fail to sort vacuolar proteins

1 reference

https://api.crossref.org/works/10.1016%2FS1369-5274%2800%2900102-8

7 January 2021

Disruption of genes encoding subunits of yeast vacuolar H(+)-ATPase causes conditional lethality

1 reference

https://api.crossref.org/works/10.1016%2FS1369-5274%2800%2900102-8

7 January 2021

Calcineurin is required for virulence of Cryptococcus neoformans

1 reference

https://api.crossref.org/works/10.1016%2FS1369-5274%2800%2900102-8

7 January 2021

Sensitivity of yeast glycolytic enzymes to chloroquine

1 reference

https://api.crossref.org/works/10.1016%2FS1369-5274%2800%2900102-8

7 January 2021

Uptake of chloroquine and hydroxychloroquine by human blood leucocytes in vitro: relation to cellular concentrations during antirheumatic therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1369-5274%2800%2900102-8

7 January 2021

Animal toxicity and pharmacokinetics of hydroxychloroquine sulfate

1 reference

https://api.crossref.org/works/10.1016%2FS1369-5274%2800%2900102-8

7 January 2021

Inhibition of human immunodeficiency virus type 1 replication by hydroxychloroquine in T cells and monocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1369-5274%2800%2900102-8

7 January 2021

Hydroxychloroquine treatment of patients with human immunodeficiency virus type 1.

1 reference

https://api.crossref.org/works/10.1016%2FS1369-5274%2800%2900102-8

7 January 2021

The preferential inhibition of Bacillus subtilis spore outgrowth by chloroquine

1 reference

https://api.crossref.org/works/10.1016%2FS1369-5274%2800%2900102-8

7 January 2021

Inhibition of tubercle bacilli in cultured human macrophages by chloroquine used alone and in combination with streptomycin, isoniazid, pyrazinamide, and two metabolites of vitamin D3

1 reference

https://api.crossref.org/works/10.1016%2FS1369-5274%2800%2900102-8

7 January 2021

Inhibition of the Salmonella typhi oral vaccine strain, Ty21a, by mefloquine and chloroquine

1 reference

https://api.crossref.org/works/10.1016%2FS1369-5274%2800%2900102-8

7 January 2021

Antimicrobial activities of mefloquine and a series of related compounds

1 reference

https://api.crossref.org/works/10.1016%2FS1369-5274%2800%2900102-8

7 January 2021

10.1016/S1369-5274(00)00102-8

Identifiers

DOI

1 reference

30 July 2017

1 reference